<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2202210535
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1983
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        MINIDIAB 5 mg tablet
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        GLIPIZIDE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        5
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        30
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        9.6
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="PFIZER" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            PFIZER
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 612]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Abdulrehman Algosaibi G.T.C.
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            PFIZER
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        A10BB07
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>This medicine contains glipizide which is one of a group of medicines called sulfonylureas.</p><p>Minidiab is used to treat diabetes (Type II, non-insulin-dependent diabetes) and helps to lower your blood glucose (sugar) levels, when a change in diet alone is not enough to control the condition.</p><p>Diabetics produce too much glucose due to a lack of insulin in the body. This can be</p><p>controlled by Minidiab, which reduces high blood glucose (sugar) levels by increasing insulin production.</p><p>You must talk to a doctor if you do not feel better or if you feel worse after taking this medicine.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not take Minidiab </strong></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you are allergic to glipizide, similar antidiabetic medicines or any of the other ingredients of this medicine (listed in section 6).</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you have insulin-dependent diabetes (also called juvenile or Type I diabetes) which would have probably started in your childhood.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you have ketone bodies and sugar in your urine (this may mean you may have diabetic ketoacidosis).</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you suffer from episodes of unconsciousness (this may mean you may have diabetic coma).</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you have problems with your kidneys or liver.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you are pregnant, planning to become pregnant or breast-feeding.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you are currently taking miconazole to treat fungal infections.</p><p>&nbsp;</p><p><strong>Warnings and precautions </strong></p><p>Talk to your doctor or pharmacist before using Minidiab :</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you have been told that you have problems with your adrenal or pituitary glands.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you are about to have major surgery, have had a recent injury (trauma) or develop a fever or severe infection. (See Section 3 &ldquo;If you are going to have an operation&rdquo; for further information).</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you suffer from G6PD deficiency (a disease that causes abnormal destruction of your red blood cells).</p><p>&nbsp;</p><p>You should test your blood and urine glucose regularly, particularly if you are elderly, debilitated or malnourished. If the results of the tests are outside the limits recommended by your doctor you should contact them immediately.</p><p>&nbsp;</p><p>Minidiab can cause hypoglycaemia (low blood sugar levels), which is characterised by confusion, faintness, sweating, dizziness, drowsiness, headache, shakiness (tremor) and visual disturbances. (These symptoms may also be unrelated to hypoglycaemia). Low blood sugar levels can be prevented by taking a regular intake of carbohydrates (e.g. bread, or other products containing starch/sugar). You should eat regular meals, and not exercise heavily or for a long period without eating something first.</p><p><strong>&nbsp;</strong></p><p><strong>Other medicines and Minidiab</strong></p><p>Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.</p><p>&nbsp;</p><p>When given with Minidiab, the following medicines may <strong>reduce </strong>your blood sugar</p><p>levels too much:</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Miconazole, fluconazole or voriconazole (used to treat fungal infections).</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Non-steroidal anti-inflammatory agents (used to treat muscle and joint pain e.g. phenylbutazone).</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Aspirin or aspirin like medicines known as salicylates (usually used as pain killers).</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Beta-blockers (used to treat high blood pressure and certain heart conditions e.g. propranolol).</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Angiotensin converting enzyme (ACE) inhibitors (used to treat high blood pressure e.g. captopril).</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cimetidine (used to treat stomach and duodenal ulcers and other digestive disorders).</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Sulfonamides or chloramphenicol (used to treat bacterial infections).</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Quinolones (used to treat bacterial infections).</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Monoamine oxidase inhibitors (used to treat depression).</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Probenecid (drugs used to treat gout).</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Coumarin anticoagulants (used to treat blood clots e.g. warfarin).</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Fibrates (used to treat high cholesterol e.g. clofibrate).</p><p>&nbsp;</p><p>The following medicines may <strong>increase </strong>your blood sugar levels too much when given</p><p>with Minidiab:</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Danazol (a hormone treatment).</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Phenothiazines tranquillisers (used to treat psychiatric conditions e.g. chlorpromazine, thioridazine).</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Corticosteroids (used to treat inflammatory conditions (e.g. prednisolone).</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Sympathomimetic agents, such as nasal decongestants and bronchodilators used to treat asthma (e.g. salbutamol, isoprenaline).</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hormonal agents, including oral contraceptives (the Pill) and hormone replacement therapy (HRT).</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Thiazides or other diuretics (water tablets e.g. bendroflumethiazide).</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Thyroid products (used to treat patients with a low production of thyroid hormones).</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Phenytoin (used to treat epilepsy).</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Nicotinic acid (used in vitamin supplements and to lower cholesterol and other lipid levels).</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Calcium channel blocking agents (used to treat angina and high blood pressure e.g. nifedepine or verapamil).</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Isoniazid (used to treat tuberculosis).</p><p>&nbsp;</p><p><strong>Minidiab with food, drink and alcohol</strong></p><p>As food may delay absorption of the drug, each dose should be taken 30 minutes before food.</p><p>Try to avoid alcohol. Alcoholic drinks (wine, beer, spirits) can further increase the reduction in blood sugar levels and could cause unconsciousness (hypoglycaemic coma).</p><p>&nbsp;</p><p><strong>Pregnancy, breast-feeding and fertility </strong></p><p>If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.</p><p>&nbsp;</p><p><strong>Driving and using machines </strong></p><p>Minidiab should not affect your ability to drive or use machines. However, you should be careful when you have just started taking this medicine or if you don&rsquo;t use it regularly.</p><p>Be aware of the symptoms of low blood sugar levels (hypoglycaemia). These are characterised by confusion, faintness, sweating, dizziness, drowsiness, headache shakiness (tremor) and visual disturbances.</p><p>If you are affected, do not drive or operate machines.</p><p>&nbsp;</p><p><strong>Minidiab contains lactose monohydrate</strong></p><p>Lactose monohydrate is a type of sugar. If you have been told that you have an intolerance to some sugars, contact your doctor before taking this medicinal product.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.</p><p>&nbsp;</p><p>Minidiab should only be taken by mouth. It is important that you take your tablets according to the instructions of your doctor. These will be written on the label of the pack. Do not take more Minidiab than your doctor has recommended.</p><p>Your dose will be adapted to your individual requirements. Some patients, whose condition is usually controlled by diet alone, may only require Minidiab for a short time.</p><p>&nbsp;</p><p>The recommended dose is:</p><p><strong>Adults </strong></p><p>The initial dose is usually 5 mg, taken approximately 30 minutes before breakfast or the midday meal, although this may be lower in some patients.</p><p>If you are elderly, have mild diabetes or suffer from liver or kidney problems you may be started on 2.5 mg daily.</p><p>If your doctor feels your dose needs to be altered, they will instruct you to adjust the dose in small increments, usually in 2.5 &ndash; 5 mg steps.</p><p>The maximum recommended daily dose is 20 mg.</p><p>The label on the pack will tell you what dose YOU should take and how often to take it. If you are still not sure, ask your doctor or pharmacist.</p><p>Do not stop taking the tablets or adjust your dosage without seeing your doctor. Stopping the medicine may make your diabetes worse.</p><p>&nbsp;</p><p><strong>Use in children and adolescents</strong></p><p>Minidiab is not recommended for use in children or adolescents.</p><p>&nbsp;</p><p><strong>If you take more Minidiab than you should </strong></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you accidentally take too many tablets, seek medical advice immediately.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you suffer faintness, confusion, drowsiness, headache, dizziness, sweating or shakiness and visual disturbances, these may be symptoms of low blood sugar. You should eat or drink something sugary.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you suffer fits or loss of consciousness occur, someone should seek urgent medical assistance for you.</p><p>&nbsp;</p><p><strong>If you forget to take Minidiab </strong></p><p>If you miss a dose, it is important that you take your medicine as soon as you remember or feel faint, otherwise your blood sugar will become too high and you may go into a coma (or fall unconscious).</p><p>Do not take a double dose to make up for a forgotten dose.</p><p>&nbsp;</p><p><strong>If you stop taking Minidiab</strong></p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do not stop taking your tablets or alter the dose you are currently taking without seeing your doctor first. Stopping these tablets may make your diabetes worse.</p><p>&nbsp;</p><p><strong>If you are going to have an operation </strong></p><p>If you are going to have major surgery or you have recently suffered a severe illness or infection, diabetic control may be lost. At such times it may be necessary to temporarily stop using Minidiab and take insulin.</p><p>&nbsp;</p><p>If you have any further questions on the use of this medicine, ask your doctor or pharmacist.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them.</p><p>The majority are temporary and disappear on reducing the dose or on stopping treatment.</p><p>Do not stop taking the tablets or adjust your dosage without seeing your doctor.</p><p><strong>&nbsp;</strong></p><p><strong>Reasons for contacting your doctor immediately </strong></p><p><strong>Tell your doctor immediately </strong>if you experience any of the following symptoms after taking this medicine. Although they are very rare, these symptoms can be serious.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; An allergic reaction such as sudden wheeziness, difficulty in breathing, swelling of eyelids, face or lips, rash or itching (especially affecting the whole body). Allergic reactions (including very rarely, death) have been reported with drugs similar to Minidiab</p><p>&nbsp;</p><p><strong>Other side effects that may occur are as follows: </strong></p><p><strong>Common: may affect up to 1 in 10 people</strong></p><p>hypoglycaemia (not enough sugar in the blood)</p><p>feeling sick (nausea)</p><p>diarrhoea</p><p>pain in the stomach</p><p><strong>&nbsp;</strong></p><p><strong>Uncommon: may affect up to 1 in 100 people</strong></p><p>dizziness</p><p>drowsiness</p><p>shakiness (tremor)</p><p>blurred vision</p><p>being sick (vomiting)</p><p>jaundice (yellowing of the skin and eyes, itching and dark urine)</p><p>eczema (inflammation of skin)</p><p>&nbsp;</p><p><strong>Not known: frequency cannot be estimated from the available data</strong></p><p>agranulocytosis (deficiency of a type of white blood cells)</p><p>leukopenia<strong> </strong>(reduction in white blood cells count)</p><p>thrombocytopenia (reduction in platelet count)</p><p>haemolytic anaemia (abnormal breakdown of red blood cells)</p><p>pancytopenia (decreased count of all type of blood cells)</p><p>porphyria non-acute</p><p>redness (erythema)</p><p>itching (pruritus)</p><p>rash (red, bumpy, or measle-like)</p><p>itching, skin redness or inflammation (dermatitis allergic)</p><p>pale red, raised, itchy bumps (urticaria)</p><p>sensitivity to light</p><p>reduction in blood sodium (hyponatraenamia)</p><p>confusion</p><p>headache</p><p>visual disturbances, double vision</p><p>constipation</p><p>inflammation of the liver (hepatitis) and abnormal hepatic functions</p><p>malaise (general discomfort)</p><p>abnormal laboratory tests</p><p>&nbsp;</p><p><strong>Reporting of side effects</strong></p><p>If you get any side effects, talk to your doctoror pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system . By reporting side effects you can help provide more information on the safety of this medicine.</p><p><strong>To Report side effects</strong></p><p>&nbsp;</p><ul><li>Saudi Arabia</li></ul><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>National Pharmacovigilance and Drug Safety Centre ( NPC )</p><ul><li>Fax: +966 11 205 7662</li><li>Call NPC at +966-11-2038222, Ext 2317-2356-2340</li><li>Call center: 19999</li><li>E-mail: npc.drug@sfda.gov.sa</li><li>Website: https://ade.sfda.gov.sa/</li></ul><p><strong>&nbsp;</strong></p></td></tr></tbody></table><p><strong>&nbsp;</strong></p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep Minidiab out of the sight and reach of children.</p><p>&nbsp;</p><p>Do not use Minidiab after the expiry date which is printed on the label.carton after EXP. The expiry date refers to the last day of that month.</p><p>&nbsp;</p><p>Shelf life: 36 months.</p><p>&nbsp;</p><p>Store below 30C.</p><p>&nbsp;</p><p>Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help &nbsp;protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The active ingredient is 5 mg glipizide.</p><p>&bull;&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; The other ingredients are microcrystalline cellulose, starch, stearic acid, and lactose.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Minidiab 5 mg tablets are white, biconvex tablets. They are available in packs of 30 tablets in blister strips. 
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Pfizer Italia Srl, Ascoli Piceno, Italy.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This leaflet was last revised in February 2018 
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p style="direction: rtl;">يحتوي هذا الدواء على&nbsp; جليبيزايد&nbsp;&nbsp; جليبيزايد ، وهو ينتمي لمجموعة من الأدوية تُسمى مركبات السلفونيل يوريا.</p><p style="direction: rtl;">يُستخدم مينيدياب لعلاج داء السكري (داء السكري من النوع الثاني غير المعتمد على الإنسولين)، وهو يساعد على خفض مستويات الجلوكوز (السكر) في دمك عندما لا يكون تغيير النظام الغذائي وحده كافيًا للتحكم في الحالة.</p><p style="direction: rtl;">تنتج أجسام مرضى السكري كمية مفرطة من الجلوكوز نتيجة نقص الإنسولين في الجسم. يمكن التحكم في هذا الأمر بواسطة مينيدياب، الذي يقوم بخفض مستويات الجلوكوز (السكر) المرتفعة في الدم من خلال زيادة إنتاج الإنسولين.</p><p style="direction: rtl;">يجب أن تتحدث إلى أحد الأطباء إذا لم تشعر بتحسن أو إذا ساءت حالتك بعد تناول هذا الدواء.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p style="direction: rtl;"><strong>لا تتناول مينيدياب </strong></p><p style="direction: rtl;">في الحالات التالية:</p><p style="direction: rtl;">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كنت تعاني من الحساسية تجاه جيلبيزيد، أو الأدوية المضادة للسكري المشابهة أو أيٍ من مكونات هذا الدواء (المدرجة في الفقرة 6&nbsp; جليبيزايد&nbsp;&nbsp; جليبيزايد &nbsp;جليبيزايد ).</p><p style="direction: rtl;">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت مصابًا بالسكري المعتمد على الإنسولين (ويُعرف أيضًا بالسكري اليفعي أو السكري من النوع الأول) والذي سيكون من المحتمل أن إصابتك به قد بدأت في طفولتك.</p><p style="direction: rtl;">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من وجود أجسام كيتونية وسكر في بولك (قد يعني ذلك أنك قد تكون مصابًا بالحماض الكيتوني السكري).</p><p style="direction: rtl;">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من نوبات إغماء (قد يعني ذلك أنك قد تكون مصابًا بغيبوبة سكرية).</p><p style="direction: rtl;">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من مشكلات في الكلى أو الكبد.</p><p style="direction: rtl;">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنتِ حاملًا أو تخططين للحمل أو كنتِ ترضعين رضاعة طبيعية.</p><p style="direction: rtl;">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت حاليًا تتناول ميكونازول لعلاج عدوى فطرية.</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;"><strong>تحذيرات واحتياطات </strong></p><p style="direction: rtl;">تحدث إلى طبيبك أو الصيدلي قبل تناول مينيدياب</p><p style="direction: rtl;">في الحالات التالية:</p><p style="direction: rtl;">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; علمت أنك تعاني من مشكلات في الغدة الكظرية أو النخامية.</p><p style="direction: rtl;">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت على وشك الخضوع لجراحة كبرى أو أُصبت إصابة حديثة (الرضح) أو ظهرت لديك حمى أو عدوى شديدة. (انظر القسم 3 &quot;في حالة الخضوع لعملية جراحية&quot; للحصول على المزيد من المعلومات).</p><p style="direction: rtl;">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من نقص إنزيم G6PD (وهو مرض يُسبب تدميرًا غير طبيعي لخلايا&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p style="direction: rtl;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الدم الحمراء).</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;">يبنغي عليك الخضوع لاختبارات دورية لقياس مستويات الجلوكوز في دمك وبولك، خاصةً إذا كنت من كبار السن أو كنت تعاني من الوهن أو سوء التغذية. إذا كانت نتائج الاختبارات خارج الحدود التي يوصي بها طبيبك، ينبغي عليك الاتصال به على الفور.</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;">يمكن لمينيدياب أن يسبب نقص سكر الدم (انخفاض مستويات السكر في الدم)، والذي يظهر علامات الإصابة بالتشوش والإغماء والتعرق والدوار والنعاس والصداع والارتجاف (الرعاش) واضطرابات الرؤية. (قد لا تكون هذه الأعراض مرتبطة أيضاً بنقص سكر الدم). يمكن الوقاية من انخفاض مستويات السكر في الدم بتناول حصص منتظمة من الكربوهيدرات (مثل الخبز وغيره من المنتجات التي تحتوي على النشا/السكر). ينبغي عليك تناول وجباتك بانتظام وتجنب التمرينات الرياضية المجهِدة أو المطوّلة دون تناول شيء ما أولًا.</p><p style="direction: rtl;"><strong>&nbsp;</strong></p><p style="direction: rtl;"><strong>الأدوية الأخرى ومينيدياب</strong></p><p style="direction: rtl;">أخبِر طبيبك أو الصيدلي إذا كنت تتناول أو تناولت مؤخرًا أو قد تتناول أي أدوية أخرى.</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;">قد تسبب الأدوية التالية، إذا أُعطيت بالتزامن مع مينيدياب، <strong>انخفاض</strong> مستويات السكر في دمك</p><p style="direction: rtl;">بصورة مفرطة:</p><p style="direction: rtl;">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ميكونازول أو فلوكونازول أو فوريكونازول (تُستخدم لعلاج العدوى الفطرية).</p><p style="direction: rtl;">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مضادات الالتهاب غير الستيرويدية (تُستخدم لعلاج آلام العضلات والمفاصل، مثل فينيل بيوتازون).</p><p style="direction: rtl;">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الأسبرين أو الأدوية الشبيهة بالأسبرين، والتي تعرف بالساليسالات (تُستخدم غالبًا كمسكنات للألم).</p><p style="direction: rtl;">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; محصرات بيتا (تُستخدم لعلاج ارتفاع ضغط الدم وبعض الأمراض القلبية مثل بروبرانولول).</p><p style="direction: rtl;">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مثبطات الإنزيم المحوِّل للأنجيوتنسين (ACE) (تُستخدم لعلاج ارتفاع ضغط الدم مثل كابتوبريل).</p><p style="direction: rtl;">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; سيميتيدين (يُستخدم لعلاج قرح المعدة والاثنى عشر وغيرها من الاضطرابات الهضمية).</p><p style="direction: rtl;">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; السلفوناميدات أو كلورامفينيكول (يُستخدم لعلاج العدوى البكتيرية).</p><p style="direction: rtl;">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الكينولونات (تستخدم لعلاج العدوى البكتيرية).</p><p style="direction: rtl;">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مثبطات إنزيم أكسيداز الأمينات الأحادية (تُستخدم لعلاج الاكتئاب).</p><p style="direction: rtl;">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; بروبينيسيد (أدوية تُستخدم لعلاج النقرس).</p><p style="direction: rtl;">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مضادات التجلط المشتقة من الكومارين (تُستخدم لعلاج جلطات الدم، مثل الوارفارين).</p><p style="direction: rtl;">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الفيبرات (تُستخدم لعلاج ارتفاع مستوى الكوليسترول مثل كلوفيبرات).</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;">&bull; قد تسبب الأدوية التالية <strong>ارتفاع</strong> مستويات السكر في دمك بصورة مفرطة، إذا أعطيت بالتزامن</p><p style="direction: rtl;">مع مينيدياب:</p><p style="direction: rtl;">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; دانازول (علاج هرموني).</p><p style="direction: rtl;">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المهدئات المشتقة من الفينوثيازينات (تُستخدم لعلاج الحالات المرضية النفسية، مثل كلوربرومازين وثيوريدازين).</p><p style="direction: rtl;">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الستيرويدات القشرية (تُستخدم لعلاج الحالات الالتهابية (مثل البريدنيزولون).</p><p style="direction: rtl;">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المحاكيات الودية، مثل مزيلات احتقان الأنف وموسعات الشعب الهوائية التي تُستخدم لعلاج الربو (مثل سالبيوتامول وأيزوبرينالين).</p><p style="direction: rtl;">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ادوية الهرمونات، بما فيها موانع الحمل التي تؤخذ عبر الفم (الحبة) والعلاج بالهرمونات البديلة (HRT).</p><p style="direction: rtl;">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الثيازيدات أو غيرها من مدرات البول (أقراص الماء مثل بندروفلوميثيازيد).</p><p style="direction: rtl;">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الادوية المشتقة من الهرمونات الدرقية (تُستخدم لعلاج المرضى ذوي الإنتاج المنخفض للهرمونات الدرقية).</p><p style="direction: rtl;">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الفنيتوين (يُستخدم لعلاج الصرع).</p><p style="direction: rtl;">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حمض النيكوتينيك (يُستخدم في المكملات الفيتامينية ولخفض مستويات الكوليسترول وغيره من الدهون في الدم).</p><p style="direction: rtl;">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حاصرات قنوات الكالسيوم (تُستخدم لعلاج الذبحات الصدرية وارتفاع ضغط الدم مثل نيفيديبين أو فيراباميل).</p><p style="direction: rtl;">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إيزونيازيد (يُستخدم لعلاج الدرن).</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;"><strong>تناول مينيدياب مع الطعام والشراب والكحوليات</strong></p><p style="direction: rtl;">ينبغي تناول كل جرعة قبل تناول الطعام بحوالي 30 دقيقة، حيث قد يؤخر الطعام امتصاص الدواء.</p><p style="direction: rtl;">احرص على تجنب تعاطي الكحول. يمكن للمشروبات الكحولية (كالنبيذ أو الجعة أو الخمور) زيادة انخفاض مستويات السكر في الدم وقد تسبب الإغماء (غيبوبة نقص سكر الدم).</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;"><strong>الحمل والرضاعة الطبيعية والخصوبة </strong></p><p style="direction: rtl;">إذا كنتِ حاملًا أو كنتِ ترضعين رضاعة طبيعية، أو تعتقدين أنكِ ربما تكونين حاملًا، أو تخططين للإنجاب، فاستشيري طبيبكِ أو الصيدلي قبل تناول هذا الدواء.</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;"><strong>القيادة واستخدام الآلات </strong></p><p style="direction: rtl;">من المفترض ألا يؤثر مينيدياب على قدرتك على قيادة السيارات واستخدام الآلات. ومع ذلك، عليك توخي الحذر إذا كنت بدأت لتوك في تناول هذا الدواء أو إذا كنت لا تتناوله بانتظام.</p><p style="direction: rtl;">انتبه لظهور أعراض انخفاض مستويات السكر في الدم (نقص سكر الدم). وهي تتضمن التشوش والإغماء والتعرّق والدوار والنعاس والصداع والارتجاف (الرعاش) واضطرابات الرؤية.</p><p style="direction: rtl;">إذا أصابك أي منها، فتجنب القيادة أو تشغيل الآلات.</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;"><strong>يحتوي مينيدياب على اللاكتوز أحادي الهيدرات</strong></p><p style="direction: rtl;">يعد اللاكتوز أحادي الهيدرات نوعًا من أنواع السكر. إذا علمت أنك لا تستطيع تحمل بعض السكريات، فاتصل بطبيبك قبل تناول هذا المنتج الدوائي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p style="direction: rtl;">احرص دومًا على تناول هذا الدواء تمامًا كما أخبرك طبيبك أو الصيدلي. استشر طبيبك أو الصيدلي إذا لم تكن متأكدًا مما يجب عليك فعله.</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;">ينبغي تناول مينيدياب فقط عبر الفم. من المهم أن تحرص على تناول أقراصك وفقًا لتعليمات طبيبك. ستجد هذه التعليمات مكتوبة على ملصق العبوة. لا تتناول جرعة من مينيدياب أكبر مما أوصى بها طبيبك.</p><p style="direction: rtl;">ستكون جرعتك متوافقة مع احتياجاتك الشخصية. قد يحتاج بعض المرضى الذين يمكن التحكم في مرضهم عادةً بضبط النظام الغذائي وحده لاستخدام مينيدياب لفترة قصيرة فقط.</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;">الجرعة الموصى بها هي:</p><p style="direction: rtl;"><strong>البالغون </strong></p><p style="direction: rtl;">عادةً ما تكون الجرعة المبدئية 5 ملجم، ويتم تناولها قبل وجبة الإفطار أو وجبة منتصف اليوم بـ30 دقيقة تقريبًا، ولكن قد تقل الجرعة في حالة بعض المرضى.</p><p style="direction: rtl;">إذا كنت مسنًا أو تعاني من داء السكري بشكل طفيف أو تعاني من مشكلات في الكبد أو الكلى، قد تبدأ جرعتك بـ 2.5 ملجم يوميًا.</p><p style="direction: rtl;">إذا شعر طبيبك بالحاجة إلى تعديل جرعتك، فسوف يطلب منك تعديل الجرعة بزيادات صغيرة، عادةً ما تكون مقدارها 2.5 - 5 ملجم على مراحل.</p><p style="direction: rtl;">الجرعة القصوى اليومية الموصى بها هي 20 ملجم.</p><p style="direction: rtl;">سيطلعك ملصق عبوة الدواء على الجرعة التي عليك تناولها وكذلك على معدّل التناول. إذا كنت لا تزال غير متأكد، فاسأل طبيبك أو الصيدلي.</p><p style="direction: rtl;">لا تتوقف عن تناول الأقراص ولا تُعدّل جرعتك دون الرجوع إلى طبيبك. قد يسبب إيقاف الدواء تفاقم حالة السكري لديك.</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;"><strong>الاستخدام مع الأطفال والمراهقين</strong></p><p style="direction: rtl;">لا يوصى باستخدام مينيدياب لعلاج الأطفال أو المراهقين.</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;"><strong>إذا تناولت جرعة من مينيدياب أكبر مما ينبغي </strong></p><p style="direction: rtl;">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا تناولت دون قصد كمية من الأقراص أكبر مما ينبغي، فالجأ إلى المشورة الطبية على الفور.</p><p style="direction: rtl;">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من الاغماء والتشوش والنعاس والصداع والدوار والتعرق أو الارتجاف واضطرابات الرؤية، فقد تكون هذه أعراضًا لانخفاض سكر الدم. ينبغي عليك تناول أطعمة أو مشروبات تحتوي على السكريات.</p><p style="direction: rtl;">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا أُصبت بنوبات أو فقدت وعيك، ينبغي على أحدهم اللجوء للمساعدة الطبية الفورية لأجلك.</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;"><strong>في حالة نسيان تناول مينيدياب </strong></p><p style="direction: rtl;">إذا نسيت تناول إحدى الجرعات، فمن المهم أن تتناول دواءك بمجرد تذكرك أو شعورك بالاغماء، وإلا قد يرتفع مستوى سكر دمك بشكل مفرط وقد تصاب بغيبوبة (أو تفقد الوعي).</p><p style="direction: rtl;">لا تتناول جرعة مضاعفة لتعويض جرعة منسية.</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;"><strong>في حالة التوقف عن تناول مينيدياب</strong></p><p style="direction: rtl;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا تتوقف عن تناول أقراصك ولا تقم بتغيير الجرعة التي تتناولها حاليًا دون الرجوع لطبيبك أولًا. إيقافك تناول هذه الأقراص قد يجعل حالة السكري الخاصة بك أسوأ.</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;"><strong>في حالة الخضوع لعملية جراحية </strong></p><p style="direction: rtl;">إذا كنت ستخضع لجراحة كبرى أو كنت قد أصبت مؤخرًا بمرض أو عدوى شديدة، فقد تفقد التحكم في داء السكري. وفي مثل هذه الحالات، قد يكون ضروريًا إيقاف استخدام مينيدياب مؤقتًا واستخدام الإنسولين.</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;">إذا كان لديك المزيد من الأسئلة بشأن استخدام هذا الدواء، فاسأل طبيبك أو الصيدلي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p style="direction: rtl;">كما هو الحال بالنسبة لجميع الأدوية، قد يسبب هذا الدواء آثارًا جانبية، غير أنها لا تصيب الجميع. معظم هذه الآثار مؤقتة وتختفي عند خفض الجرعة أو إيقاف العلاج.</p><p style="direction: rtl;">لا تتوقف عن تناول الأقراص ولا تُعدّل جرعتك دون الرجوع إلى طبيبك.</p><p style="direction: rtl;"><strong>&nbsp;</strong></p><p style="direction: rtl;"><strong>أسباب تستدعي الاتصال بطبيبك على الفور </strong></p><p style="direction: rtl;"><strong>أخبر طبيبك في الحال</strong> إذا أصبت بأي من الأعراض التالية بعد تناول هذا الدواء. وعلى الرغم من أن هذه الأعراض نادرة جدًا، فإنها قد تكون خطيرة.</p><p style="direction: rtl;">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تفاعل حساسية، كالحالات المفاجئة من الأزيز أو صعوبة التنفس أو تورم الجفون أو الوجه أو الشفتين، أو الطفح الجلدي أو الحكة (خاصة التي تؤثر على الجسم بأكمله). تم الإبلاغ عن الإصابة بتفاعلات حساسية (وصلت في حالات نادرة جدًا إلى الوفاة) عند استخدام عقاقير مشابهة لمينيدياب</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;"><strong>الآثار الجانبية الأخرى التي قد تحدث هي كما يلي: </strong></p><p style="direction: rtl;"><strong>شائعة: قد تصيب ما يصل إلى شخص واحد من بين كل 10 أشخاص</strong></p><p style="direction: rtl;">نقص سكر الدم (عدم كفاية كمية السكر في الدم)</p><p style="direction: rtl;">الشعور بالإعياء (الغثيان)</p><p style="direction: rtl;">الإسهال</p><p style="direction: rtl;">ألم في المعدة</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;"><strong>غير شائعة: قد تصيب ما يصل إلى شخص واحد من بين كل 100 شخص</strong></p><p style="direction: rtl;">الدوار</p><p style="direction: rtl;">النعاس</p><p style="direction: rtl;">الارتجاف (الرعاش)</p><p style="direction: rtl;">تغيُّم الرؤية</p><p style="direction: rtl;">الشعور بالتوعك (القيء)</p><p style="direction: rtl;">اليرقان (اصفرار الجلد والعينين والحكة والبول الداكن)</p><p style="direction: rtl;">إكزيما (التهاب الجلد)</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;"><strong>غير معروفة: لا يمكن تقدير نسبة التكرار استنادًا إلى البيانات المتاحة</strong></p><p style="direction: rtl;">نَدْرَةُ المُحَبَّبات (نقص نوع من أنواع خلايا الدم البيضاء)</p><p style="direction: rtl;">قلة الكريات البيضاء<strong> </strong>(انخفاض في تعداد خلايا الدم البيضاء)</p><p style="direction: rtl;">قلة الصفيحات (انخفاض في تعداد الصفائح الدموية)</p><p style="direction: rtl;">فقر الدم الانحلالي (انهيار غير عادي في خلايا الدم الحمراء)</p><p style="direction: rtl;">نقص خلايا الدم الشامل (انخفاض تعداد جميع أنواع خلايا الدم)</p><p style="direction: rtl;">البرفيرية غير حادة</p><p style="direction: rtl;">احمرار (بقع حمراء)</p><p style="direction: rtl;">الحكة</p><p style="direction: rtl;">الطفح الجلدي (أحمر أو متكتل أو شبيه بالحصبة)</p><p style="direction: rtl;">الحكة، أو احمرار أو التهاب االجلد (حساسية التهاب الجلد)</p><p style="direction: rtl;">تكتلات بارزة ومثيرة للحكة ذات لون أحمر باهت (أرتيكاريا)</p><p style="direction: rtl;">الحساسية تجاه الضوء</p><p style="direction: rtl;">انخفاض مستوى الصوديوم في الدم (نقص صوديوم الدم)</p><p style="direction: rtl;">التشوش</p><p style="direction: rtl;">الصداع</p><p style="direction: rtl;">اضطرابات الرؤية، الرؤية المزدوجة</p><p style="direction: rtl;">الإمساك</p><p style="direction: rtl;">التهاب الكبد (التهاب الكبد الوبائي) واختلال وظائف الكبد</p><p style="direction: rtl;">التوعك (شعور عام بالانزعاج)</p><p style="direction: rtl;">نتائج اختبارات معملية غير طبيعية</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;"><strong>الإبلاغ عن الآثار الجانبية</strong></p><p style="direction: rtl;">إذا تعرضت للإصابة بأي آثار جانبية، فتحدث إلى طبيبك أو الصيدلي أو الممرضة. يتضمن ذلك أي آثار جانبية محتملة لم يرد ذكرها في هذه النشرة. يمكنك أيضًا الإبلاغ عن الآثار الجانبية مباشرةً عبر نظام الإبلاغ القومي. بإبلاغك عن الآثار الجانبية، يمكنك المساعدة في توفير المزيد من المعلومات حول سلامة هذا الدواء.</p><p style="direction: rtl;"><strong>&nbsp;</strong></p><p style="direction: rtl;"><strong>للإبلاغ عن الآثار الجانبية</strong></p><p style="direction: rtl;"><em>&nbsp;</em></p><p style="direction: rtl;"><em>&middot;&nbsp;&nbsp;&nbsp; </em>المملكة العربية السعودية</p><p style="direction: rtl;"><em>&nbsp;</em></p><table border="0" cellspacing="0" cellpadding="0" style="direction:rtl"><tbody><tr><td style="vertical-align:top"><p>المركز الوطني للتيقظ والسلامة الدوائية (NPC)</p><p><em>&middot;&nbsp;&nbsp;&nbsp; </em>فاكس: 0966112057662</p><p><em>&middot;&nbsp;&nbsp;&nbsp; </em>اتصل بالمركز الوطني للتيقظ والسلامة الدوائية على الرقم: 00966112038222، تحويلة: 2317-2356-2340</p><p><em>&middot;&nbsp;&nbsp;&nbsp; </em>مركز الاتصالات: 19999</p><p><em>&middot;&nbsp;&nbsp;&nbsp; </em>البريد الإلكتروني: npc.drug@sfda.gov.sa</p><p><em>&middot;&nbsp;&nbsp;&nbsp; </em>الموقع الإلكتروني: https://ade.sfda.gov.sa</p><p><em>&nbsp;</em></p></td></tr></tbody></table><p style="direction: rtl;">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p style="direction: rtl;">احتفظ بمينيدياب بعيدًا عن مرأى ومتناول الأطفال.</p><p style="direction: rtl;">لا تستخدم مينيدياب بعد مرور تاريخ انتهاء الصلاحية المطبوع على الملصق، العبوة الكرتونية بعد الرمز &quot;EXP&quot;. يشير تاريخ انتهاء الصلاحية إلى آخر يوم في ذلك الشهر.</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;">صلاحية المستحضر 36 شهر.</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;">يحفظ عند درجة حرارة اقل من 30 درجة مئوية.</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;">لا تتخلص من أي أدوية عبر مياه الصرف أو في المخلفات المنزلية. اسأل الصيدلي الخاص بك عن كيفية التخلص من الأدوية التي لم تعد تستخدمها. ستساعد هذه الإجراءات في حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p style="direction: rtl;">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المُكوّن الفعال هو&nbsp; جليبيزايد&nbsp;&nbsp; جليبيزايد &nbsp;جليبيزايد 5 ملجم.</p><p style="direction: rtl;">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المكونات الأخرى هي سيليولوز بلوري مكروي ونشا وحمض الستياريك واللاكتوز.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            أقراص مينيدياب 5 ملجم هي أقراص بيضاء مُحدبة الوجهين. الأقراص متوفرة في عبوات بها ٣۰ قرصاً في أشرطة . 
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>Pfizer Italia Srl, Ascoli Piceno, Italy</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            تمت المراجعة الأخيرة لهذه النشرة في فبراير/شباط 2018
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Minidiab 5 mg Tablets.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                5 mg Glipizide.

Excipient with known effect:
Each tablet contains 153 mg lactose monohydrate. 
 
For the full list of excipients, see section 6.1. 

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Tablet.
White biconvex tablets scored on both sides. 
The score line is not intended for breaking the tablet.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Glipizide is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Posology</u></p><p>&nbsp;</p><p>As for any hypoglycaemic agent, dosage must be adapted for each individual case.</p><p>&nbsp;</p><p>Short term administration of glipizide may be sufficient during periods of transient loss of control in patients usually controlled well on diet.</p><p>&nbsp;</p><p>In general, glipizide should be given shortly before a meal to achieve the greatest reduction in post-prandial hyperglycaemia.</p><p>&nbsp;</p><p><u>Initial Dose</u></p><p>The recommended starting dose is 5 mg, given before breakfast or the midday meal. Mild diabetics, geriatric patients or those with liver disease may be started on 2.5 mg.</p><p>&nbsp;</p><p><u>Titration</u></p><p>Dosage adjustments should ordinarily be in increments of 2.5 mg or 5 mg, as determined by blood glucose response. At least several days should elapse between titration steps. The maximum recommended single dose is 15 mg. If this is not sufficient, splitting the daily dosage may prove effective. Doses above 15 mg should ordinarily be divided.</p><p>&nbsp;</p><p><u>Maintenance</u></p><p>Some patients may be effectively controlled on a once-a-day regimen. Total daily dosage above 15 mg should ordinarily be divided.</p><p>&nbsp;</p><p>The maximum recommended daily dosage is 20 mg<em>.</em></p><p>&nbsp;</p><p><u>Paediatric population</u></p><p>Safety and effectiveness in children have not been established.</p><p>&nbsp;</p><p><u>Use in Elderly and High-Risk Patients</u></p><p>In elderly, debilitated and &nbsp;malnourished patients or patients with an impaired renal or hepatic function, the initial and maintenance dosing should be conservative to avoid hypoglycaemic reactions (see Initial Dose and section 4.4).</p><p>&nbsp;</p><p><u>Patients Receiving Other Oral Hypoglycaemic Agents</u></p><p>As with other sulfonylurea class hypoglycaemics, no transition period is necessary when transferring patients to glipizide. Patients should be observed carefully (1-2 weeks) for hypoglycaemia when being transferred from longer half-life sulfonylureas (e.g. chlorpropamide) to glipizide due to potential overlapping of drug effect.</p><p>&nbsp;</p><p><u>Method of administration</u></p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; For oral use only.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                1.	Hypersensitivity to glipizide, other sulfonylureas or sulfonamides, or to any of the excipients listed in section 6.1.
2.	Insulin-dependent diabetes mellitus, diabetic ketoacidosis, diabetic coma.
3.	Severe renal or hepatic insufficiency.
4.	Patients treated with miconazole (see section 4.5).
5.	Pregnancy and lactation.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Glucose-6-phosphate dehydrogenase deficiency </u></p><p>Since glipizide belongs to the class of sulfonylurea agents, caution should be used in patients with G6PD deficiency. Treatment of patients with G6PD deficiency with sulfonylurea agents can lead to haemolytic anaemia and a non-sulfonylurea alternative should be considered.</p><p><u>&nbsp;</u></p><p><u>Hypoglycaemia</u></p><p>All sulfonylurea agents are capable of producing severe hypoglycaemia. Renal or hepatic insufficiency may cause elevated blood levels of glipizide and the latter may also diminish gluconeogenic capacity, both of which increase the risk of serious hypoglycaemic reactions. Elderly, debilitated or malnourished patients and those with adrenal or pituitary insufficiency are particularly susceptible to the hypoglycaemic action of glucose-lowering drugs.</p><p>&nbsp;</p><p>Hypoglycaemia may be difficult to recognise in the elderly, and in people who are taking beta-adrenergic blocking drugs (see section 4.5). Hypoglycaemia is more likely to occur when caloric- intake is deficient, after severe or prolonged exercise, when alcohol is ingested, or when more than one glucose-lowering drug is used.</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Loss of control of blood glucose</p><p>When a patient stabilised on a diabetic regimen is exposed to stress such as fever, trauma, infection, or surgery, a loss of control may occur. At such times, it may be necessary to discontinue glipizide and administer insulin.</p><p>&nbsp;</p><p>The effectiveness of any oral hypoglycaemic drug, including glipizide, in lowering blood glucose to a desired level decreases in many patients over a period of time, which may be due to progression of the severity of diabetes or due to diminished responsiveness to the drug. This phenomenon is known as secondary failure, to distinguish it from primary failure in which the drug is ineffective in an individual patient when first given. Adequate adjustment of dose and adherence to diet should be assessed before classifying a patient as a secondary failure.</p><p><u>&nbsp;</u></p><p><u>Renal and Hepatic Disease</u></p><p>The pharmacokinetics and/or pharmacodynamics of glipizide may be affected in patients with impaired renal or hepatic function. If hypoglycaemia should occur in such patients, it may be prolonged and appropriate management should be instituted.</p><p>&nbsp;</p><p><u>Information for Patients</u></p><p>Patients should be informed of the potential risks and advantages of glipizide and of alternative modes of therapy. They should also be informed about the importance of adherence to dietary instructions, of a regular exercise program, and of regular testing of urine and/or blood glucose.</p><p>&nbsp;</p><p>The risks of hypoglycaemia, its symptoms and treatment, and conditions that predispose to its development should be explained to patients and responsible family members. Primary and secondary failure should also be explained.</p><p>&nbsp;</p><p><u>Laboratory Tests</u></p><p>Blood and urine glucose should be monitored periodically. Measurement of glycosylated haemoglobin may be useful.</p><p>&nbsp;</p><p>This product contains lactose. Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency, glucose-galactose malabsorption should not take this medicine.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>The following products are likely to increase the hypoglycaemic effect:</u></p><p>&nbsp;</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong><u>Contraindicated combinations</u></strong></p><p>&nbsp;</p><p><em><u>Miconazole</u></em></p><p>Increase in hypoglycaemic effect, possibly leading to symptoms of hypoglycaemia or even coma.</p><p>&nbsp;</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong><u>Inadvisable combinations</u></strong></p><p>&nbsp;</p><p><em><u>Nonsteroidal Anti-inflammatory Drugs (e.g. phenylbutazone)</u></em></p><p>Increase in hypoglycaemic effect of sulfonylureas (displacement of sulfonylurea binding to plasma proteins and/or decrease in sulfonylurea elimination).</p><p>&nbsp;</p><p><em><u>Alcohol</u></em></p><p>Increase in hypoglycaemic reaction, which can lead to hypoglycaemic coma.</p><p>&nbsp;</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong><u>Combinations requiring precaution</u></strong></p><p>&nbsp;</p><p><em><u>Fluconazole</u></em></p><p>Increase in the half-life of the sulfonylurea, possibly giving rise to symptoms of hypoglycaemia.</p><p>&nbsp;</p><p><em><u>Voriconazole</u></em><em> </em></p><p>Although not studied, voriconazole may increase the plasma levels of sulfonylureas, (e.g. tolbutamide, glipizide and glyburide) and therefore cause hypoglycaemia. Careful monitoring of blood glucose is recommended during co-administration.</p><p>&nbsp;</p><p><em><u>Salicylates (acetylsalicylic acid)</u></em></p><p>Increase in hypoglycaemic effect by high doses of acetylsalicylic acid (hypoglycaemic action of the acetylsalicylic acid).</p><p>&nbsp;</p><p><em><u>Beta-blockers</u></em></p><p>All beta-blockers mask some of the symptoms of hypoglycaemia (i.e. palpitations and tachycardia). Most non cardio selective beta-blockers increase the incidence and severity of hypoglycaemia.</p><p>&nbsp;</p><p><em><u>Angiotensin-converting Enzyme Inhibitors</u></em></p><p>The use of angiotensin-converting enzyme inhibitors may lead to an increased hypoglycaemic effect in diabetic patients treated with sulfonylureas.</p><p>&nbsp;</p><p><em><u>Cimetidine</u></em></p><p>The use of cimetidine may be associated with a reduction in post prandial blood glucose in patients treated with glipizide.</p><p>&nbsp;</p><p>The hypoglycaemic action of sulfonylureas, in general may also be potentiated by monoamine oxidase inhibitors, quinolones and drugs that are highly protein bound, such as sulfonamides, chloramphenicol, probenecid, coumarins and fibrates.</p><p>&nbsp;</p><p>When such drugs are administered to (or withdrawn from) a patient receiving glipizide, the patient should be observed closely for hypoglycaemia (or loss of control).</p><p>&nbsp;</p><p><u>The following products could lead to hyperglycaemia</u>:</p><p>&nbsp;</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong><u>Inadvisable combinations</u></strong></p><p>&nbsp;</p><p><em><u>Danazol</u></em></p><p>Diabetogenic effect of danazol. If it cannot be avoided, warn the patient and step up self- monitoring of blood glucose and urine. Possibly adjust the dosage of antidiabetic agent during treatment with danazol and after its discontinuation.</p><p>&nbsp;</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong><u>Combinations requiring precaution</u></strong></p><p>&nbsp;</p><p><em><u>Phenothiazines (e.g. chlorpromazine) at High Doses (&gt; 100 mg/day of chlorpromazine)</u></em></p><p>Elevation in blood glucose (reduction in insulin release).</p><p>&nbsp;</p><p><em><u>Corticosteroids</u></em></p><p>Elevation in blood glucose.</p><p>&nbsp;</p><p><em><u>Sympathomimetics (e.g. ritodrine, salbutamol, terbutaline)</u></em></p><p>Elevation in blood glucose due to beta-2-adrenoceptor stimulation.</p><p>&nbsp;</p><p><em><u>Progestogens</u></em></p><p>Diabetogenic effects of high-dose progestogens. Warn the patient and step up self-monitoring of blood glucose and urine. Possibly adjust the dosage of antidiabetic agent during treatment with the neuroleptics, corticoids or progestogen and after discontinuation.</p><p>&nbsp;</p><p>Other drugs that may produce hyperglycaemia and lead to a loss of control include the thiazides and other diuretics, thyroid products, oestrogens, oral contraceptives, phenytoin, nicotinic acid, calcium channel blocking drugs, and isoniazid.</p><p>&nbsp;</p><p>When such drugs are administered to (or withdrawn from) a patient receiving glipizide, the patient should be observed closely for hypoglycaemia.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Pregnancy</u></p><p>Glipizide is contraindicated in pregnancy.</p><p><em>&nbsp;</em></p><p>Glipizide was found to be mildly fetotoxic in rat reproductive studies. No teratogenic effects were found in rat or rabbit studies.</p><p>&nbsp;</p><p>Prolonged severe hypoglycaemia (4- 10 days) has been reported in neonates born to mothers who were receiving a sulfonylurea drug at the time of delivery.</p><p>&nbsp;</p><p>Because recent information suggests that abnormal blood glucose levels during pregnancy are associated with a higher incidence of congenital abnormalities, many experts recommend that insulin be used during pregnancy to maintain blood glucose levels as close to normal as possible.</p><p>&nbsp;</p><p><u>Breast-feeding</u></p><p>No data are available on secretion into breast milk. Therefore glipizide is contraindicated in lactation.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The effect of glipizide on the ability to drive or operate machines has not been studied; however, there is no evidence to suggest that glipizide may affect these abilities. Patients should be aware of the symptoms of hypoglycaemia and be careful about driving and the use of machines, especially when optimum stabilisation has not been achieved, for example during the change-over from other medications or during irregular use.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The majority of side effects have been dose related, transient, and have responded to dose reduction or withdrawal of the medication. However, clinical experience thus far has shown that, as with other sulfonylureas, some side effects associated with hypersensitivity may be severe and deaths have been reported in some instances.</p><p>&nbsp;</p><p>The reported adverse reactions, which may possibly be associated with glipizide, are listed in the following table by system organ class and frequency group: Very common (&ge;1/10), Common (&ge;1/100 to &lt;1/10), Uncommon (&ge;1/1,000 to &lt;1/100), Rare (&ge;1/10,000 to &lt; 1/1,000), Very rare (&lt; 1/10,000), Not known (cannot be estimated from available data).</p><p>&nbsp;</p><p><u>Blood and lymphatic system disorders</u>:</p><p>Not known - Leukopenia, agranulocytosis, thrombocytopenia, haemolytic anaemia, pancytopenia</p><p>&nbsp;</p><p><u>Metabolism and nutrition disorders</u>:</p><p>Common &ndash; Hypoglycaemia</p><p>Not known &ndash; Hyponatremia</p><p><u>&nbsp;</u></p><p><u>Psychiatric disorders</u>:</p><p>Not known &ndash; Confusional state#</p><p>&nbsp;</p><p><u>Nervous system disorders</u>:</p><p>Uncommon &ndash; Dizziness#, somnolence#, tremor#</p><p>Not known &ndash; Headache#</p><p>&nbsp;</p><p><u>Eye disorders</u>:</p><p>Uncommon &ndash; Vision blurred#</p><p>Not known &ndash; Diplopia#, visual impairment#, visual acuity reduced#</p><p><u>&nbsp;</u></p><p><u>Gastrointestinal disorders</u>:</p><p>Common &ndash; Nausea$, diarrhoea$, abdominal pain and upper$, abdominal pain</p><p>Uncommon &ndash; Vomiting</p><p>Not known &ndash; Constipation$</p><p>&nbsp;</p><p><u>Hepatobiliary disorders</u>:</p><p>Uncommon &ndash; Jaundice cholestatic&dagger;</p><p>Not known &ndash; Hepatic function abnormal, hepatitis</p><p>&nbsp;</p><p><u>Skin and subcutaneous tissue disorders</u>:</p><p>Uncommon &ndash; Eczema&Dagger;</p><p>Not known &ndash; Dermatitis allergic&Dagger;, erythema&Dagger;, rash morbilliform&Dagger;, rash maculopapular&Dagger;, urticaria&Dagger;, pruritus&Dagger;, photosensitivity reaction</p><p><u>&nbsp;</u></p><p><u>Congenital, familial and genetic disorders</u>:</p><p>Not known &ndash; Porphyria non-acute</p><p>&nbsp;</p><p><u>General disorders and administration site conditions</u>:</p><p>Not known &ndash; Malaise#</p><p>&nbsp;</p><p><u>Investigations</u>:</p><p>Not known &ndash; Aspartate aminotransferase increased&sect;, blood lactate dehydrogenase increased&sect;, blood alkaline phosphatase increased&sect;, blood urea increased&sect;, blood creatinine increased&sect;</p><p>&nbsp;</p><p># This is usually transient and do not require discontinuance of therapy; however, they may also be symptoms of hypoglycaemia.</p><p>$ Appear to be dose related and usually disappear on division or reduction of dosage.</p><p>&dagger; Discontinue treatment if cholestatic jaundice occurs.</p><p>&Dagger; They frequently disappear with continued therapy. However, if they persist, the drug should be discontinued.</p><p>&sect; The relationship of these abnormalities to glipizide is uncertain, and they have rarely been associated with clinical symptoms.</p><p>&nbsp;</p><p>Aplastic anaemia and disulfiram-like reactions have been reported with other sulfonylureas.</p><p>&nbsp;</p><p><strong>Reporting of suspected adverse reactions</strong><br />Reporting suspected adverse reactions after marketing authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions according to their local country requirements.</p><p><strong>To Report side effects</strong></p><p>&nbsp;</p><ul><li>Saudi Arabia</li></ul><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>National Pharmacovigilance and Drug Safety Centre ( NPC )</p><ul><li>Fax: +966 11 205 7662</li><li>Call NPC at +966-11-2038222, Ext 2317-2356-2340</li><li>Call center: 19999</li><li>E-mail: npc.drug@sfda.gov.sa</li><li>Website: https://ade.sfda.gov.sa/</li></ul><p><strong>&nbsp;</strong></p></td></tr></tbody></table><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>There is no well documented experience with glipizide overdosage. Overdosage of sulfonylureas including glipizide can produce glycaemia. Mild hypoglycaemic symptoms without loss of consciousness or neurologic findings should be treated actively with oral glucose and adjustments in drug dosage and/or meal patterns. Close monitoring should continue until the physician is assured that the patient is out of danger. Severe hypoglycaemic reactions with coma, seizure, or other neurological impairment occur infrequently, but constitute medical emergencies requiring immediate hospitalisation. If hypoglycaemic coma is diagnosed or suspected, the patient should be given a rapid intravenous injection of concentrated (50 %) glucose solution. This should be followed by a continuous infusion of a more dilute (10 %) glucose solution at a rate that will maintain the blood glucose at a level above 100 mg/dL (5.55 mmol/L). Patients should be closely monitored for a minimum of 48 hours and depending on the status of the patient at this time the physician should decide whether further monitoring is required. Clearance of glipizide from plasma may be prolonged in people with liver disease. Because of the extensive protein binding of glipizide, dialysis is unlikely to be of benefit.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Drugs used in diabetes, blood glucose lowering drugs excl. insulins, sulfonylureas, ATC code: A10BB07.</p><p><strong>&nbsp;</strong></p><p>Glipizide is an oral blood -glucose -lowering drug of the sulfonylurea class. The primary mode of action of glipizide is the stimulation of insulin secretion from the beta-cells of pancreatic islet tissue. Stimulation of insulin secretion by glipizide in response to a meal is of major importance. Fasting insulin levels are not elevated even on long-term glipizide administration, but the post-prandial insulin response continues to be enhanced after at least 6 months of treatment. The insulinotropic response to a meal occurs within 30 minutes after oral dose of glipizide in diabetic patients, but elevated insulin levels do not persist beyond the time of the meal challenge. There is also increasing evidence that extrapancreatic effects involving potentiation of insulin action form a significant component of the activity of glipizide.</p><p>&nbsp;</p><p>Blood sugar control persists for up to 24 hours after a single dose of glipizide, even though plasma levels have declined to a small fraction of peak levels by that time (see section 5.2).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Absorption</u></p><p>Gastrointestinal absorption of glipizide in humans is uniform, rapid and essentially complete. Peak plasma concentrations occur 1 to 3 hours after a single oral dose. The half-life of elimination ranges from 2 to 4 hours in normal subjects, whether given intravenously or orally. The metabolic and excretory patterns are similar with the two routes of administration, indicating that first-pass metabolism is not significant. Glipizide does not accumulate in plasma on repeated oral administration. Total absorption and disposition of an oral dose were unaffected by food in normal volunteers, but absorption was delayed by about 40 minutes. Thus, glipizide was more effective when administered about 30 minutes before, rather than with, a test meal in diabetic patients.</p><p>&nbsp;</p><p><u>Distribution</u></p><p>Protein binding was studied in serum from volunteers who received either oral or intravenous glipizide and found to be 98 % to 99 % one hour after either route of administration. The apparent volume of distribution of glipizide after intravenous administration was 11 L, indicative of localisation within the extracellular fluid compartment. In mice, no glipizide or metabolites were detectable autoradiographically in the brain or spinal cord of males or females, nor in the foetuses of pregnant females. In another study, however, very small amounts of radioactivity were detected in the foetuses of rats given labelled drug.</p><p>&nbsp;</p><p><u>Biotransformation</u></p><p>The metabolism of glipizide is extensive and occurs mainly in the liver.</p><p>&nbsp;</p><p><u>Elimination</u></p><p>The primary metabolites are inactive hydroxylation products and polar conjugates and are excreted mainly in the urine. Less than 10 % unchanged glipizide is found in urine.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Acute toxicity studies showed no specific susceptibility. The acute oral toxicity of glipizide was extremely low in all species tested (LD50 greater than 4 g/kg). Chronic toxicity tests in rats and dogs at doses up to 8.0 mg/kg did not show any evidence of toxic effects.</p><p>&nbsp;</p><p>A 20-month study in rats and an 18-month study in mice at doses up to 75 times the maximum human dose revealed no evidence of drug-related carcinogenicity. Bacterial and in vivo mutagenicity tests were uniformly negative. Studies in rats of both sexes at doses up to 75 times the maximum human dose showed no effects on fertility.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Microcrystalline cellulose&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p>Starch&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p>Stearic acid&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p>Lactose</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>None stated.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Do not use Minidiab after the expiry date which is stated on the carton / Blister after EXP:. The expiry date refers to the last day of that month.

Shelf life: 36 months.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store below 30 &deg; C</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Blister strips containing 30 tablets</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Keep out of the sight and reach of children.</p><p>&nbsp;</p><p>&nbsp;</p><p>&ldquo;Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment&rdquo;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                
Pfizer Italia SrI Ascoli Piceno, Italy 

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                August 2016
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>